Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.3285 EUR -3.38% Market Closed
Market Cap: 35.2m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gensight Biologics SA
Total Current Liabilities Peer Comparison

Comparables:
VLA
G
GNFT
IVA
ALERS
OSE

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Total Current Liabilities
€16.9m
CAGR 3-Years
-1%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Total Current Liabilities
€102.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genfit SA
PAR:GNFT
Total Current Liabilities
€36.4m
CAGR 3-Years
6%
CAGR 5-Years
-5%
CAGR 10-Years
10%
Inventiva SA
PAR:IVA
Total Current Liabilities
€50.2m
CAGR 3-Years
50%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Total Current Liabilities
€52.9m
CAGR 3-Years
20%
CAGR 5-Years
17%
CAGR 10-Years
19%
OSE Immunotherapeutics SA
PAR:OSE
Total Current Liabilities
€17.4m
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
N/A

See Also

What is Gensight Biologics SA's Total Current Liabilities?
Total Current Liabilities
16.9m EUR

Based on the financial report for Jun 30, 2024, Gensight Biologics SA's Total Current Liabilities amounts to 16.9m EUR.

What is Gensight Biologics SA's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
14%

Over the last year, the Total Current Liabilities growth was -45%. The average annual Total Current Liabilities growth rates for Gensight Biologics SA have been -1% over the past three years , 14% over the past five years .

Back to Top